Posted on February 28th, 2012 by
One quarter of patients with chronic sacroiliac joint pain may be disqualified from receiving radiofrequency ablation (RFA) treatment based on inaccurate criteria for patient selection, a new study suggests…"It does fly in the face of what we typically do," commented session moderator James Watson, MD, from the Mayo Clinic in Rochester, Minnesota. "It suggests we don't have a very good predictor of who responds and who does not respond to radiofrequency ablation in the sacroiliac joint, which is a little bit surprising," he told Medscape Medical News.
Medscape, by Kate Johnson, 02/27/2012
You must be logged-in to the site to post a comment.